Patents by Inventor George P. Stricklin

George P. Stricklin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human collagenase inhibitor, recombinant vector system for using same and recombinant DNA method for the manufacture of same
    Patent number: 6800732
    Abstract: A portable DNA sequence is disclosed which is capable of directing intracellular production of metalloproteinase inhibitors. Vectors containing this portable DNA sequence are also set forth, including the vector pUC9-F5/237P10 (ATCC Accession No. 53003). A recombinant-DNA method for the microbial production of a metalloproteinase inhibitor, which method incorporates at least one of the portable DNA sequences and the vectors disclosed herein.
    Type: Grant
    Filed: November 14, 2001
    Date of Patent: October 5, 2004
    Assignee: Amgen Inc.
    Inventors: David F. Carmichael, David C. Anderson, George P. Stricklin, Howard G. Welgus
  • Human collagenase inhibitor, recombinant vector system for using same and recombinant DNA method for the manufacture of same
    Publication number: 20030003556
    Abstract: A portable DNA sequence is disclosed which is capable of directing intracellular production of metalloproteinanse inhibitors. Vectors containing this portable DNA sequence are also set forth, including the vector pUC9-F5/237P10 (ATCC Accession No. 53003). A recombinant-DNA method for the microbial production of a metalloproteinase inhibitor, which method incorporates at least one of the portable DNA sequences and the vectors disclosed herein.
    Type: Application
    Filed: November 14, 2001
    Publication date: January 2, 2003
    Applicant: AMGEN INC.
    Inventors: David F. Carmichael, David C. Anderson, George P. Stricklin, Howard G. Welgus
  • Human collagenase inhibitor, recombinant vector system for using same and recombinant-DNA method for the manufacture of same
    Patent number: 6342374
    Abstract: A portable DNA sequence is disclosed which is capable of directing intracellular production of metalloproteinanse inhibitors. Vectors containing this portable DNA sequence are also set forth, including the vector pUC9-F5/237P10 (ATCC Accession No. 53003). A recombinant-DNA method for the microbial production of a metalloproteinase inhibitor, which method incorporates at least one of the portable DNA sequences and the vectors disclosed herein.
    Type: Grant
    Filed: December 1, 1999
    Date of Patent: January 29, 2002
    Assignee: Amgen Inc.
    Inventors: David F. Carmichael, David C. Anderson, George P. Stricklin, Howard G. Welgus
  • Human collagenase inhibitor sequence, recombinant vector system for using same and recombinant-DNA method for the manufacture of same
    Patent number: 6090585
    Abstract: A portable DNA sequence is disclosed which is capable of directing intracellular production of metalloproteinanse inhibitors. Vectors containing this portable DNA sequence are also set forth, including the vector pUC9-F5/237P10 (ATCC Accession No. 53003). A recombinant-DNA method for the microbial production of a metalloproteinase inhibitor, which method incorporates at least one of the portable DNA sequences and the vectors disclosed herein is described.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: July 18, 2000
    Assignee: Amgen Inc.
    Inventors: David F. Carmichael, David C. Anderson, George P. Stricklin, Howard G. Welgus